RG
Rathbones Group’s Vir Biotechnology VIR Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $144K | Hold |
28,611
| – | – | ﹤0.01% | 573 |
|
2025
Q1 | $185K | Hold |
28,611
| – | – | ﹤0.01% | 535 |
|
2024
Q4 | $210K | Hold |
28,611
| – | – | ﹤0.01% | 529 |
|
2024
Q3 | $214K | Hold |
28,611
| – | – | ﹤0.01% | 535 |
|
2024
Q2 | $255K | Sell |
28,611
-3,456
| -11% | -$30.8K | ﹤0.01% | 516 |
|
2024
Q1 | $325K | Hold |
32,067
| – | – | ﹤0.01% | 474 |
|
2023
Q4 | $323K | Buy |
32,067
+10,000
| +45% | +$101K | ﹤0.01% | 464 |
|
2023
Q3 | $207K | Buy |
22,067
+11,000
| +99% | +$103K | ﹤0.01% | 534 |
|
2023
Q2 | $271K | Hold |
11,067
| – | – | ﹤0.01% | 344 |
|
2023
Q1 | $258K | Hold |
11,067
| – | – | ﹤0.01% | 354 |
|
2022
Q4 | $280K | Hold |
11,067
| – | – | ﹤0.01% | 345 |
|
2022
Q3 | $213K | Hold |
11,067
| – | – | ﹤0.01% | 367 |
|
2022
Q2 | $282K | Hold |
11,067
| – | – | ﹤0.01% | 355 |
|
2022
Q1 | $285K | Hold |
11,067
| – | – | ﹤0.01% | 365 |
|
2021
Q4 | $463K | Buy |
11,067
+6,067
| +121% | +$254K | ﹤0.01% | 321 |
|
2021
Q3 | $218K | Buy |
+5,000
| New | +$218K | ﹤0.01% | 385 |
|